Ultraviolet Blood Irradiation: New Hope for Chronic COVID
By Thomas Levy, MD, JD
Ultraviolet (UV) irradiation of the blood is a very old but highly effective therapy for a wide range of infections and medical conditions. Early to moderately advanced infectious diseases were shown to be curable nearly 100% of the time. Both bacterial and viral infections have been readily resolved. Wound healing is strongly enhanced, and many different diseases and chronic medical conditions have also been shown to respond very well.
Just as important as the ability of UV irradiation to rapidly resolve infections is its ability to inactivate toxins. Such toxins include those of diphtheria and tetanus, as well as of snake venom. Nearly any toxin comprised of protein can be inactivated by UV irradiation, as it is able to denature (breakdown) proteins as well as cause them to “unfold,” which partially or completely blocks their function by changing their three-dimensional configuration. Also, once partially denatured, many proteins can then be metabolized completely and eliminated from the body.
The toxic agent that is considered to be the primary reason for most of the morbidity and mortality seen in chronic COVID patients and some patients post-vaccination is the spike protein. The spike protein is that part of the COVID pathogen that attaches to cellular receptors (ACE2) throughout the body and permits the entry of the entire pathogen into those cells. The ACE2 receptors are so widespread that there appear to be no tissues or organs in the body that are completely spared from the infectious and toxic impact of the spike protein.
The continued presence of the spike protein (Persistent Spike Protein [PSP] syndrome) in patients who have never fully recovered from COVID (chronic COVID) is becoming increasingly common and resulting in increased illness and early death in millions of people around the world. However, PSP syndrome is also commonly appearing in post-vaccination patients regardless of whether the COVID pathogen was ever contracted. This should not come as a surprise, as the purpose of the vaccine is to use mRNA to enter the genome to produce spike protein inside the body, purportedly to stimulate an immune response to the entire spike protein-containing COVID pathogen. However, it is now well-documented that many people continue to produce the spike protein long after the vaccination, resulting in the PSP syndrome. And when the vaccination is given to someone who has also contracted COVID at some point in time, it only results in a higher amount of circulating spike protein in the body. Until compelling data indicates a clear-cut benefit to patient health and longevity, consideration should be given to avoiding any of the booster shots that are designed to stimulate further production and presence of spike protein in the body.
Currently, blood testing for the spike protein is not readily available except for research laboratories. However, the PSP syndrome is closely linked to elevations of D-Dimer in the blood. D-Dimer is a product that results from the breakdown and dissolution of blood clots in the body. When there is an abnormal increase in blood clotting, there is a corresponding increase in the D-Dimer breakdown product. As it is a readily available blood test, D-Dimer testing is an excellent way to better monitor how well a chronic COVID or post-vaccination patient is responding to whatever therapies are being administered. Generally, symptom relief closely parallels the lowering or normalization of an elevated D-Dimer level.
Bio-oxidative therapies, such as vitamin C, hydrogen peroxide, ozone, hyperbaric oxygen, and ultraviolet light have all been shown to be highly effective in the inactivation and/or killing of nearly all pathogens. The COVID infective agent has been shown to be very susceptible to these therapies as well.
Very recent clinical research now shows the UV light irradiation (wavelength 254 nm) can promptly reduce and even normalize D-Dimer levels in chronic COVID patients. As expected, the normalization of the D-Dimer level is typically also accompanied by dramatic symptom relief. Currently, the D-Dimer level laboratory reference range is 0 to 500 ng/cc, or 0 to 0.5 mg/L. While UV irradiation and other effective therapies should be continued as long as the D-Dimer level is greater than 500, it is also reasonable to continue them long enough to see if the level can be dropped even further, to 300 or less, assuring a more comfortable degree of normalcy and eradication of the spike protein.
Because of the nature of the spike protein and its ability to be generated inside the cells, especially after vaccination, it is not possible at this time to regard a normalization of D-Dimer and resolution of COVID symptoms as being a definitive cure with a complete elimination of spike protein from the body. However, the Ultraviolet Blood Irradiation Protocol as established at the Riordan Clinic for some years now can be repeated as needed if symptoms recur and D-Dimer levels again rise.
Proteolytic enzyme therapy is recommended by many clinicians now to minimize or eliminate circulating spike protein. These include nattokinase, lumbrokinase, serrapeptase, and bromelain taken with N-acetylcysteine. These agents have multiple beneficial effects on health, and one or more of them should still be taken when a D-Dimer level has normalized with UV irradiation and/or other therapies. As noted earlier, UV irradiation clearly can breakdown the spike protein present in the blood. However, even spike protein fragments have been shown to be potent inflammatory and disease-causing agents. Because of this, oral proteolytic enzyme administration is still a good idea to help further breakdown any remaining protein fragments into their constituent amino acids or to a degree where phagocytic white blood cells and the immune system can then clear them out completely.
Ozone therapies and intravenous vitamin C administrations are also very important in reaching a complete clinical recovery from PSP syndrome, both of which are available at the Riordan Clinic.
Rowen R (1996) Ultraviolet blood irradiation therapy (photo-oxidation), the cure that time forgot. International Journal of Biosocial and Medical Research 14:115-132l https://www.drmichaelschoenwalder.com/wp-content/uploads/2020/12/Ultraviolet-Blood-Irradiation-Therapy-Photo-Oxidation-The-Cure-That-Time-Forgot.pdf
Heilingloh C, Aufderhorst U, Schipper L et al. (2020) Susceptibility of SARS-CoV-2 to UV irradiation. American Journal of Infection Control 48:1273-1275. PMID: 32763344
Reed N (2010) The history of ultraviolet germicidal irradiation for air disinfection. Public Health Reports 125:15-27. PMID: 20402193
evy T (2023) http://orthomolecular.org/resources/omns/v19n15.shtml
Parry P, Lefringhausen A, Turni C et al. (2023) “Spikeopathy”: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA. Biomedicines 11:2287. PMID: 37626783
Cao S, Song Z, Rong J et al. (2023) Spike protein fragments promote Alzheimer’s amyloidogenesis. ACS Applied Materials & Interfaces 15: 40317-40329. PMID: 37585091
Ultraviolet Irradiation: Tumaini Jipya kwa COVID-19 - Thomas Levy, MD, JD - Upasuaji wa damu kwa UV ni tiba ya zamani lakini yenye ufanisi sana kwa maambukizo na hali mbalimbali za matibabu. Ugonjwa wa kuambukiza wa mapema hadi wa hali ya juu unaonekana kuwa na uwezo wa kupona karibu asilimia 100 ya wakati. Maambukizo ya bakteria na ya virusi yameponywa kwa urahisi. Uponyaji wa jeraha huimarishwa sana, na magonjwa mengi tofauti na hali za matibabu ya muda mrefu pia zimeonyeshwa kujibu vizuri sana. Kwa sababu ya uwezo wa UV wa kuondoa maambukizo haraka, ni muhimu pia uwezo wake wa kuondoa sumu. Sumu hizo zinatia ndani zile za diphtheria na tetanus, na vilevile za sumu ya nyoka. Karibu sumu yoyote iliyoundwa na protini inaweza kuondolewa na mionzi ya UV, kwani ina uwezo wa kuharibu protini na pia kusababisha <unk> kufungua, <unk> ambayo kwa sehemu au kabisa huzuia kazi yao kwa kubadilisha muundo wao wa pande tatu. Pia, protini nyingi zinapopotezwa sehemu fulani, zinaweza kuchanganywa kabisa na kuondolewa mwilini. "Kama ""sumu"" ambayo inachukuliwa kuwa sababu ya msingi ya ugonjwa na vifo vinavyoonekana kwa wagonjwa wa COVID ya muda mrefu na baadhi ya wagonjwa baada ya chanjo, ni protini ya spike." Spike protein ni sehemu ya virusi vya COVID-19 ambayo huunganisha kwa receptors za seli (ACE2) katika mwili wote na inaruhusu kuingia kwa virusi vyote katika seli hizo. ACE2 receptor ni ya kawaida sana, na hakuna tishu au viungo katika mwili ambao ni kabisa kuokolewa kutoka athari ya kuambukiza na sumu ya spike protini. Uwepo wa protini ya spike (sindromu ya protini ya spike ya kudumu) kwa wagonjwa ambao hawajawahi kupona kabisa kutoka kwa COVID-19 (COVID-19 ya muda mrefu) inazidi kuwa ya kawaida na kusababisha kuongezeka kwa magonjwa na vifo vya mapema kwa mamilioni ya watu ulimwenguni. Hata hivyo, ugonjwa wa PSP pia unaonekana kwa kawaida kwa wagonjwa baada ya chanjo, bila kujali kama vimelea vya COVID vilikuwa vimepatikana. Hii haipaswi kuja kama mshangao, kwani kusudi la chanjo ni kutumia mRNA kuingia kwenye genome kutengeneza protini ya spike ndani ya mwili, kwa madai ya kuchochea majibu ya kinga kwa virusi vyote vya COVID vinavyomilikiwa na protini ya spike. Hata hivyo, sasa imethibitishwa vizuri kwamba watu wengi wanaendelea kutengeneza protini ya spike muda mrefu baada ya chanjo, na kusababisha ugonjwa wa PSP. """Wakati chanjo hiyo inapewa mtu ambaye pia amepatwa na COVID wakati fulani, inasababisha tu kiasi kikubwa cha protini ya spike inayozunguka mwili." "Kabla ya data ya kuvutia kuonyesha faida ya wazi kwa afya ya mgonjwa na urefu wa maisha, kuzingatia inapaswa kupewa kuepuka yoyote ya risasi za booster ambazo zimekusudiwa kuchochea uzalishaji zaidi na uwepo wa protini ya spike katika mwili. """ Kwa sasa, uchunguzi wa damu wa protini hiyo haupatikani kwa urahisi isipokuwa katika maabara ya utafiti. Hata hivyo, ugonjwa wa PSP unahusiana sana na kuongezeka kwa D-Dimer katika damu. D-Dimer ni bidhaa inayotokana na kuvunjika na kufutwa kwa makundi ya damu mwilini. Wakati kuna ongezeko lisilo la kawaida katika kuganda kwa damu, kuna ongezeko linalofanana katika bidhaa ya uharibifu wa D-Dimer. Kwa kuwa ni mtihani wa damu unaopatikana kwa urahisi, upimaji wa D-Dimer ni njia bora ya kufuatilia vizuri jinsi mgonjwa wa COVID-19 au mgonjwa wa baada ya chanjo anavyosimama kwa matibabu yoyote yanayotolewa. Kwa ujumla, kupunguza dalili hufanana sana na kupunguzwa au kurudishwa kwa kiwango cha juu cha D-Dimer. Tiba za bio-oxidative, kama vile vitamini C, peroksidi ya hidrojeni, ozoni, oksijeni ya hyperbaric, na mwanga wa ultraviolet zote zimeonyeshwa kuwa na ufanisi mkubwa katika kutofanya kazi na au kuua karibu vimelea vyote. Vifaa vya kuambukiza virusi vya COVID vimeonyeshwa kuwa na uwezekano mkubwa wa kupata matibabu haya pia. Utafiti wa hivi karibuni wa kliniki sasa unaonyesha kwamba mionzi ya mwanga wa UV (urefu wa mawimbi 254 nm) inaweza kupunguza haraka na hata kurudisha kiwango cha D-dimer kwa wagonjwa wa COVID. Kama inavyotarajiwa, normalization ya kiwango cha D-Dimer ni kawaida pia ikiambatana na mapumziko ya dalili ya kuvutia. Kwa sasa, kiwango cha D-dimer katika maabara ni 0 hadi 500 ng kwa cc, au 0 hadi 0.5 mg kwa lita. Wakati UV radiation na matibabu mengine ya ufanisi yanapaswa kuendelea kwa muda mrefu kama kiwango cha D-dimer ni kubwa kuliko 500, ni busara pia kuendelea nao kwa muda mrefu wa kutosha kuona kama kiwango cha inaweza kushuka hata zaidi, kwa 300 au chini, kuhakikisha kiwango cha starehe zaidi ya kawaida na uondoaji wa spike protini. "Kwa sababu ya asili ya protini ya spike na uwezo wake wa kutengenezwa ndani ya seli, haswa baada ya chanjo, haiwezekani kwa wakati huu kuzingatia kawaida ya D-dimer na utatuzi wa dalili za COVID kama tiba ya mwisho na kuondolewa kabisa kwa protini ya spike kutoka kwa mwili. """ Hata hivyo, itifaki ya mionzi ya damu ya ultraviolet kama ilivyoanzishwa katika Kliniki ya Riordan kwa miaka kadhaa sasa inaweza kurudia kama inahitajika ikiwa dalili zinarudi na viwango vya D-Dimer vinaongezeka tena. Tiba ya enzyme ya proteolytic inapendekezwa na madaktari wengi sasa ili kupunguza au kuondoa protini ya spike inayozunguka. Hizi ni pamoja na nattokinase, lumbrokinase, serrapeptase, na bromelain kuchukuliwa na N-acetylcysteine. Dawa hizi zina athari nyingi za manufaa kwa afya, na moja au zaidi ya hizo bado zinapaswa kuchukuliwa wakati kiwango cha D-dimer kimekuwa kawaida na mionzi ya UV na au matibabu mengine. Kama ilivyotajwa hapo awali, mionzi ya UV kwa wazi inaweza kuvunja protini ya spike iliyopo katika damu. Hata hivyo, hata vipande vya protini vilivyo na ncha nyingi vimeonyeshwa kuwa vitu vyenye nguvu vinavyosababisha uvimbe na magonjwa. Kwa sababu hii, matumizi ya enzymes ya proteolytic ya mdomo bado ni wazo nzuri kusaidia kuvunja zaidi vipande vya protini zilizobaki katika asidi zao za amino au kwa kiwango ambapo seli nyeupe za damu za phagocyte na mfumo wa kinga zinaweza kuziondoa kabisa. Matibabu ya ozoni na utoaji wa vitamini C kwa njia ya mshipa pia ni muhimu sana katika kufikia uponyaji kamili wa kliniki kutoka kwa ugonjwa wa PSP, ambayo yote mawili yanapatikana katika Kliniki ya Riordan. "Rowan R. (1996) ""Tiba ya radiation ya damu ya ultraviolet (photo-oxidation) ni tiba ambayo wakati umesahau.""" "Jarida la Kimataifa la Utafiti wa Biosocial na Matibabu (International Journal of Biosocial and Medical Research) linatoa utafiti wa ""Utafiti wa Biosocial na Matibabu"" (International Journal of Biosocial and Medical Research) unaoitwa ""Utafiti wa Biosocial na Matibabu"" (International Journal of Biosocial and Medical Research) na unaitwa ""Utafiti wa Biosocial na Matibabu"" (International Journal of Biosocial and Medical Research) na unaitwa ""Utafiti wa Biosocial na Matibabu"" (International Journal of Biosocial and Medical Research)." Uwezo wa SARS-CoV-2 wa kuathiriwa na mionzi ya UV American Journal of Infection Control, 48127-1275, na makala nyingine za utafiti. "Kama ilivyoelezwa katika utafiti wa ""Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani wa Ulimani.""" Ripoti za Afya ya Umma 125:15-27 (P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S.S. - P.S.S.S. - P.S.S.S.S. - P.S.S.S.S. - P.S.S.S.S. - P.S.S.S.S.S. - P.S.S.S.S.S.S. - P.S.S.S.S.S.S.S. - P.S. "Soma ""Spaikopati"" - protini ya spike ya COVID-19 ni ya kuambukiza, kutoka kwa virusi na mRNA ya chanjo." Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: Biomedical: (P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S. - P.S.S.S. - P.S.S.S. - P.S.S.S. - P.S.S.S.S. - P.S.S.S.S. - P.S.S.S.S.S. - P.S.S.S.S.S. - P.S.S.S.S.S.S. - P.S.S.S.S.S.S.S. - P.S.S.S Spike protini vipande kukuza Alzheimer's amyloidogenesis. ACS Applied Materials & Interfaces (AMSI) ni moja ya makampuni ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia ya teknolojia. PMID: 3758509